News

Get Updated on Future Industry Events

MVA Calendar Service

Subscribe to the MVA Newsletters

Take part in building up competences and competitiveness in Medicon Valley.

Print | Tell a friend

Top image

MVA Newsletter, March 2009

MVA Project News

High Interest in Exclusive Meetings with Thomas Jonsson, the Medicon Valley Ambassador in Japan

Recently MVA hosted a series of arranged meetings between Thomas Jonsson, the Medicon Valley Ambassador in Japan, and Medicon Valley companies who hold interest in the Japanese market. The result was two days with a fully booked meeting schedule. Read more

13 New Members Have Joined the Alliance

MVA is pleased to announce that 13 new companies have decided to join MVA since the beginning of 2009. MVA is delighted to welcome Astellas Pharma A/S, A+ Science, Biosphere, COBIS A/S, Dantrials, E. Merck AB, Epsilon AB, iNovacia AB, MEABCO A/S, MedNest, Protista Biotechnology AB and Sundhedsdoktor. Read more about some of the new members below in this newsletter.

Information Meeting: EU Funding for Health Related Research Projects - 20 April

Medicon Valley Alliance and EuroCenter (part of the Danish Agency for Science, Technology and Innovation) will host an information meeting on the upcoming call for proposals concerning the health theme in EU's 7th framework programme for research and technological development (FP7). This is a unique opportunity to learn more about EU's 7th framework programme and to get a head start on the next call for proposals, which is expected to be published by the European Commission during the summer 2009. Target group: All researchers and SMEs interested in European life science research projects. Read more (in Danish)

Meeting Medicon Valley 2009: Redefining Funding Strategies - 5 May 2009

Make sure to join the exciting one-day conference by Medicon Valley Alliance on how the current financial situation is influencing the life science industry. The conference will focus on the changing investment environment and in particular the ability of innovative companies to raise capital and engage in valuable partnerships. The conference programme features recognised experts from the international pharma and investment industry. More than 100 executives and seniors have already signed up to explore international funding opportunities and to network with regional decision makers. Read more

The Medicon Valley Golf Championship - 28 May 2009

Medicon Valley Alliance presents the first Medicon Valley Golf Championship, a new MVA member event for executive decision makers within Medicon Valley. Besides an outstanding golf and nature experience at Barsebäck's Masters Course, the championship also provides the opportunity of meeting and networking with peers from the life science sector in Medicon Valley. Read more

News from Medicon Valley

Clinical Trials Update

Read the latest updates from TopoTarget, Bavarian Nordic, BioInvent, Camurus, BioInvent and Genzyme.

People on the Move

Read the latest people news about Copenhagen University Hospital and DTU Nanotech.

Medicon Valley TV - Latest News

Medicon Valley TV provides you with an ongoing flow of news from the region and gives MVA members the opportunity to reach a wider audience in the region as well as internationally. Visit www.mva.org/MVTV where you can view, among other things, the following news:

	EU Funding for Health Related Research Projects A new call for the EU Health Programme is expected in summer 2009. Annette Lorenzen, Chief Advisor at EuroCenter, Danish Agency for Science, Technology and Information, tells about funding possibilities and international networks. View more and read about the meeting here.
	ALK and Novozymes Enter Collaboration ALK and Novozymes have signed an agreement regarding industrially produced allergens, also called recombinant allergens, for use in ALK's future allergy immunotherapy tablets. Henrik Jacobi, EVP, Research & Development, ALK and Svend Erik Licht, Senoir Director, Novozymes, explains. View more
	Lundbeck's Acquisition of Ovation: Interview With Ulf Wiinberg, CEO and Ole Vahlgren, Vice President The acquisition of US-based Ovation Pharmaceuticals realises Lundbeck's strategic goal of building a US commercial platform and will contribute to Lundbeck's mid and long-term growth prospects. Ulf Wiinberg, CEO and Ole Vahlgren, Vice President, Corporate Business Development & Strategy, Lundbeck, explains. View more
	Workshop on US Business Culture During February and March MVA has organised five workshops about business culture in the UK, US, Germany, Japan and China. View the news about the US business culture workshop or join the last workshop on 19 March about business culture in China.

University of Lund's Diabetes Center Given the Go Ahead for Testing Diabetes on Infants

In a few weeks, trials begin on the first children that are to be vaccinated with Glutamic Acid Decarboxylase (GAD). The hope is that GAD can inhibit the development of type-1 diabetes. Read more (in Swedish)

DTU Develops Atlas of Hereditary Diseases

A universal connection between genes, protein complexes and tissue types for more than 1,000 hereditary diseases has now been mapped and made accessible for the public. It is the result of a biological system research project from DTU in collaboration with researchers from Harvard Medical School. Read more (in Danish)

Savene/Totect Reaches Profitability for TopoTarget

Sales of TopoTarget's Savene/Totect for 2008 were close to doubling the results for 2007. Read more

New Hope for Complicated Breast Cancer Treatments

A third of all breast cancer patients have the so-called oestrogen-negative tumours which cannot be treated with effective hormonal medicine like Tamoxifen. A group of researchers at the University of Lund and the University Hospital MAS have now discovered a possible future treatment method. Read more (in Swedish)

New World-Class Biobank in Denmark

The National Serum Institute has been awarded a grant of DKK 121 million from the Danish Minister for Science and the Novo Nordisk Fund in order to strengthen the Danish health research. The initiative will benefit research into the causes, prevention and treatment of diseases. Read more (in Danish)

Swedish Pharmacy Market to be Liberalized

The Swedish Government have submitted a proposal on the re-regulation of the pharmacy market to the Riksdag on 20 February 2009. The proposal will bring about a liberalization of the rules on operating a pharmacy in Sweden. Read more

For more news about Medicon Valley, visit the MVA news section.

Media News

Life Science Clusters Magazine: Articles about Medicon Valley and the Ambassador Programme

The latest edition of Life Science Clusters features both an article about Medicon Valley and the current financial challenges and an article about the Medicon Valley Life Science Ambassador Programme. Read the online version of Life Science Clusters here (registration required).

Other News

Conference on European Spallation Source Scandinavia and Denmark's Participation - 25 March 2009

Should Denmark invest almost EUR 150 million in the construction of the European Spallation Source (ESS) to be placed in Lund, Sweden? Join the one-day conference in Copenhagen with 15 clarifying contributions on the ESS and its proposed place in Lund, Sweden's offer to host the facility, and Denmark's considerations of being a co-host. Read more.

Do you want to know which other life science events takes place in Medicon Valley? View www.mva.org/calendar or sign up for the MVA Calendar Service.

New Members of MVA

Copenhagen Bio Science Park

Copenhagen Bio Science Park (COBIS) is the first dedicated biotechnological science park in Copenhagen offering space for up to 50 companies and development projects within life science. It represents an ambitious growth environment creating the conditions for biotechnological successes of tomorrow. COBIS has something to offer you whether you represent an established life science company, a CRO or simply if you have a good idea and just need help to get started. It is the ideal place for innovative life science companies or entrepreneurs researching within biotechnology.

Contact: www.cobis.dk - mmj@symbion.dk - +45 39 17 99 99

DanTrials

DanTrials is a hospital-based CRO performing clinical trials in healthy volunteers and patients. DanTrials' clinical trial unit ensures safe, dedicated, flexible, and highly efficient conduct of clinical trials from phase I to III. The location within a university hospital enables unique access to a variety of patient groups and interaction with experts within a broad range of therapeutic areas. DanTrials knows how important time-efficiency is to sponsors and the goal of the experienced staff is not only to deliver data of superb quality, but also to ensure timely conduct of clinical trials.

Contact: www.dantrials.com - info@dantrials.com - +45 72 10 01 88

iNovacia

iNovacia is an organization fully focused on providing External Research, bridging academic and Pharma target discovery to preclinical development. Our primary goal is to reduce the risk in early drug discovery and deliver solid IP with a strong SAR. iNovacia has a long track record as a Center of Excellence in Lead Discovery from first Kabi, then Pharmacia/Upjohn/Searle and lastly Biovitrum, where iNovacia was spun out in May 2006 as a fully independent company. Since then, we have proven the efficiency and expertise by competing successfully on a global scale and experience that of our more than 20 projects, we have NCEs generated at iNovacia in clinical development and several in preclinical.

Contact: www.inovacia.se - info@inovacia.se - +46 8 50 10 30 40

MedNest

MedNest delivers Business and Clinical Operations services to companies looking for an experienced partner to operate their organic or inorganic growth projects for the US markets. We are specialized in the Medical Technology Convergence space, at the intersection of Drug - Device and Diagnostics - Healthcare IT technology platforms. Our key activities are organized along the lines of the most important challenges that entrepreneurs face when launching new products into the following US markets: Compliance, Clinical Validation and Value Proposition, Market Opportunities and Related Healthcare Economics, Targeting and First Commercial wins or Partnerships, Project and Growth Financing.

Contact: www.mednest.com - info@mednest.com - +1 973 699 1579

SundhedsDoktor

SundhedsDoktor (Health Doctor) is a leading provider of health care solutions based in Copenhagen, Denmark. Our core competencies are: 1) Health care solutions including health checks, massage, physiotherapy, chiropractics, zone therapy, weight- and fitness-programs, etc., 2) strategic integration of health care solutions in private and public organizations and 3) knowledge and competence centre within health care solutions. Among our customers are Novo Nordisk, The Danish National Bank, Danske Bank, Danica Pension, IKEA, and ISS. For more information see www.sundhedsdoktor.dk.